Winocour, Peter
-
British Journal of Diabetes Vol. 14 No. 1 (2014) - ABCD News
Metamorphosis: from the Newsletter to the Journal
Abstract HTML PDF -
British Journal of Diabetes Vol. 18 No. 2 (2018): April / May / June 2018 - Editorials
Diabetes and kidney disease: insult added to injury
Abstract PDF HTML -
British Journal of Diabetes Vol. 18 No. 2 (2018): April / May / June 2018 - Guidelines
Managing hyperglycaemia in patients with diabetes and diabetic nephropathy–chronic kidney disease Summary of recommendations 2018
Abstract PDF HTML -
British Journal of Diabetes Ahead of Print Articles - Guidelines
Clinical practice guidelines for management of hyperglycaemia in adults with diabetic kidney disease
Abstract PDF HTML -
British Journal of Diabetes Vol. 17 No. 2 (2017) - Guidelines
Management of lipids in adults with diabetes mellitus and nephropathy and/or chronic kidney disease: summary of joint guidance from the Association of British Clinical Diabetologists (ABCD) and the Renal Association (RA)
Abstract HTML PDF -
British Journal of Diabetes Vol. 19 No. 1 (2019): June 2019 - Original Research
A survey of the management of 16–18-year-olds presenting with diabetic ketoacidosis in the UK: a need for standardisation
Abstract PDF HTML -
British Journal of Diabetes Vol. 20 No. 2 (2020): December 2020 - Original Research
Effects of canagliflozin are mostly observed at first follow-up, within 6 months of commencement: results for the ABCD canagliflozin audit
Abstract PDF HTML -
British Journal of Diabetes Vol. 15 No. 4 (2015) - Learning from practice
An evaluation of the safety and efficacy of a variable rate intravenous insulin infusion in the management of hyperglycaemia in acute coronary syndrome: experience of the TITAN-ACS
Abstract HTML PDF -
British Journal of Diabetes Vol. 21 No. 1 (2021): June 2021 - Position Statements
Cardiovascular impact of new drugs (GLP-1 and gliflozins): the ABCD position statement
Abstract PDF HTML -
British Journal of Diabetes Vol. 16 No. 4 (2016) - Position Statements
Association of British Clinical Diabetologists (ABCD) position statement on the risk of diabetic ketoacidosis associated with the use of sodium-glucose cotransporter-2 inhibitors
Abstract HTML PDF -
British Journal of Diabetes Vol. 19 No. 1 (2019): June 2019 - Position Statements
Association of British Clinical Diabetologists (ABCD) position statement on the use of sodium-glucose cotransporter-2 inhibitors in type 1 diabetes (updated 2019)
Abstract PDF HTML -
British Journal of Diabetes Vol. 20 No. 1 (2020): June 2020 - Editorials
Supporting people with diabetes during the COVID-19 pandemic without face-to-face appointments
Abstract PDF HTML -
British Journal of Diabetes Vol. 20 No. 2 (2020): December 2020 - Position Statements
Association of British Clinical Diabetologists (ABCD) and Diabetes UK joint position statement and recommendations on the use of sodium-glucose co-transporter inhibitors with insulin for treatment of type 1 diabetes (updated October 2020)
Abstract PDF HTML -
British Journal of Diabetes Vol. 21 No. 1 (2021): June 2021 - Position Statements
ABCD position statement on risk stratification of adult patients with diabetes during COVID-19 pandemic
Abstract PDF HTML -
British Journal of Diabetes Vol. 15 No. 4 (2015) - Original Research
Training needs in adolescent and young adult health and transition in UK paediatric and adult higher specialist trainees in endocrinology and diabetes
Abstract HTML PDF -
British Journal of Diabetes Vol. 19 No. 2 (2019): DECEMBER 2019 - Original Research
Reductions in alanine aminotransferase levels with liraglutide treatment are greatest in those with raised baseline levels and are independent of weight loss: real-world outcome data from the ABCD Nationwide Liraglutide Audit
Abstract PDF HTML -
British Journal of Diabetes Vol. 16 No. 2 (2016) - Current Topics
Management of adults with diabetes on the haemodialysis unit: summary of new guidance from the Joint British Diabetes Societies (JBDS) and the Renal Association
Abstract HTML PDF
